' New Tool ' in Arsenal for Second-Line Treatment of GEP-NETs ' New Tool ' in Arsenal for Second-Line Treatment of GEP-NETs

A new first-in-class radionuclide therapy offers an option for patients with gastroenteropancreatic neuroendocrine tumors (GEP-NETs).Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news